首页> European journal of neurology> Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients.

Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lisa,Schwarz

第一单位： Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

作者： Lisa,Schwarz ^[1] ; Nilufar,Akbari ^[2] ; Harald,Prüss ^[3] ; Andreas,Meisel ^[4] ; Franziska,Scheibe ^[4]

作者单位： Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[1] Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[2] Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.;German Center for Neurodegenerative Diseases Berlin, Berlin, Germany. ^[3] Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.;Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center, Berlin, Germany. ^[4]

关键词 autoimmune encephalitis bortezomib daratumumab intensive care unit plasma cell depletion

医学主题词人类(Humans);中年人(Middle Aged);预后(Prognosis);回顾性研究(Retrospective Studies);浆细胞(Plasma Cells);重症监护病房(Intensive Care Units)

DOI 10.1111/ene.15585

PMID 36176208

发布时间 2023-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交